Immix Biopharma Earnings
NASDAQ: IMMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.46+0.17 (+1.83%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Fri, Nov 6, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.19
Immix Biopharma earnings summary
Immix Biopharma is scheduled to report Sep/2026 earnings on Nov 6, 2026, with analysts expecting EPS of $-0.19.
Summary generated from market data by MetaCap's automated system. Methodology